Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1998
Report date:
1998

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Cyclopropyl methyl ketone
EC Number:
212-146-4
EC Name:
Cyclopropyl methyl ketone
Cas Number:
765-43-5
Molecular formula:
C5H8O
IUPAC Name:
1-cyclopropylethan-1-one
Test material form:
other: liquid

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: healthy, young adult animals
- Fasting period before study: 16 hours. 3 hours after application food was offered ad libitum.
- Housing:max. 5 animals/cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 30-70%
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 08.09.1997 To: 23.10.1997

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
In the first step three male rats were given a single oral application of the test substance at a limit-dose of 2000 mg/kg bodyweight. No rats died after the treatment, so three female rats were treated in the same way. Since mortalities occurred in two females, three male rats were treated with the dose
level of 200 mg/kg bw. No mortalities were observed in the animals after administration of this dose. Therefore three female rats were treated in the
same way.
The dosing formulation was applied to the rats by gavage using a stomach tube (2.23 cm3/kg for 2000mg/kg and 0.22 cm3/kg for 200 mg/kg bodyweight).
Doses:
200 and 2000 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: soon after dosing and 1, 2, 3, 4, 5 and 6 h after dosing and once daily thereafter
- Frequency of weighing: day 0 (prior to dosing), day 7, day 14 or after death of an animal
- Necropsy of survivors performed: yes
- Other examinations performed: gross examination of organs at necropsy

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 500 - < 2 000 mg/kg bw
Based on:
test mat.
Mortality:
2000 mg/kg bw: 0/3 male animals, 2/3 female animals
200 mg/kg bw: 0/3 male animals, 0/3 female animals
500 mg/kg bw: 0/3 male animals, 0/3 female animals
Clinical signs:
other: Male animals dosed with 2000 mg/kg bw, showed moderate to severe clinical signs on the day of treatment. Half an hour until 6 hours p.a. signs like sedation, abdormal and lateral position, paddling movements, vocalisation, difficult and hurried breathing,
Gross pathology:
The macroscopical examination of the deceased two female animals dosed with 2000 mg/kg bw revealed autolytic changes of all tissues. The surviving female showed agglutinations of tissues of the addominal cavity (liver, spleen, pancreas and stomach).
All male animals dosed with 2000 mg/kg bw and all male/female animals dosed with 200 mg/kg bw showed no macroscopical abnormalities.

Any other information on results incl. tables

Amendment to the final report:

In an amendment to the final report an experiment with the dose group 500 mg/kg bw was reported.

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Remarks:
Migrated information
Conclusions:
In this oral toxicity study in the rat an LD50 between 500 and 2000 mg/kg bw was found for the test item.